$JAZZ Company News Speculators live by the sword, die

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$JAZZ Company News

Speculators live by the sword, die by the sword 3:13 p.m. July 8, 2014 - The Trading Deck
Two reasons a top is not yet imminent 2:12 p.m. July 3, 2014 - The Trading Deck
Apple and Beats,Tesla and Missouri car dealers, plus the missing momo 8:36 a.m. May 9, 2014 - Barbara Kollmeyer
Jazz Pharmaceuticals swings to first-quarter loss 10:53 p.m. May 8, 2014 - MarketWatch.com
Dow industrials hesitate at major resistance 11:23 a.m. April 23, 2014 - Michael Ashbaugh
The case for the bears weakens 2:55 p.m. Feb. 25, 2014 - The Trading Deck
A stock that protects your identity and your portfolio 12:56 p.m. Feb. 3, 2014 - The Trading Deck
13 stocks set to outperform in 2014 from Sabrient's David Brown 8:21 p.m. Jan. 14, 2014 - blogs.marketwatch.com
Sex bot on Volcker, dream gigs at Twitter and Wall Street's whiffs 9:27 a.m. Dec. 11, 2013 - Shawn Langlois
Dow industrials vie for all-time closing high 12:09 p.m. Nov. 21, 2013 - Michael Ashbaugh
One biotech that shouldn’t be missed 10:26 a.m. June 5, 2013 - The Trading Deck
Charting the S&P’s test of record territory 11:57 a.m. March 12, 2013 - Michael Ashbaugh
Charting the S&P’s test of record territory 11:51 a.m. March 12, 2013 - Michael Ashbaugh
S&P 500 nears next technical test 12:07 p.m. Nov. 30, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 12:11 p.m. Oct. 2, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 11:50 a.m. Oct. 2, 2012 - Michael Ashbaugh
4 stocks with charts pointing higher 6:58 a.m. Oct. 2, 2012 - The Trading Deck
Dow, Nasdaq hesitate at the range top 11:22 a.m. Sept. 24, 2012 - Michael Ashbaugh
Jazz Pharmaceuticals gains on Xyrem court ruling 12:15 p.m. Sept. 17, 2012 - Val Brickates Kennedy
Meda buys women's-health portfolio in US for $95M 2:56 a.m. Sept. 6, 2012 - MarketWatch.com


Jazz Pharmaceuticals (JAZZ) Shares March Higher, Can It Continue? - Tale of the Tape 9:06 a.m. Today - Zacks.com
JP Morgan Says Jazz Pharmaceuticals Positioned For 'Organic Growth And Acquisition' 1:02 p.m. Aug. 19, 2014 - benzinga.com
Why Jazz Pharmaceuticals (JAZZ) Stock Is Gaining Today 12:54 p.m. Aug. 19, 2014 - TheStreet.com
Will This Coverage Initiation Help Jazz Pharmaceuticals (JAZZ) Stock Today? 9:27 a.m. Aug. 19, 2014 - TheStreet.com
Analysts' Actions: El Pollo Loco, Jazz Pharmaceuticals, SolarCity 8:43 a.m. Aug. 19, 2014 - TheStreet.com
Top Analyst Upgrades and Downgrades: Applied Materials, Pollo Loco, Dollar General, SolarCity, Urban Outfitters and More 7:47 a.m. Aug. 19, 2014 - 247WallSt.com
Jazz, Celgene Lead Top 4 Drugmaker Profit Margins 12:46 p.m. Aug. 18, 2014 - Investors Business Daily
Jazz Pharmaceuticals Is Taking Two Routes To Growth 5:10 p.m. Aug. 15, 2014 - Investors Business Daily
3 Health Care Stocks Pushing The Sector Higher 1:03 p.m. Aug. 15, 2014 - TheStreet.com
Insider Trading Alert - JAZZ, ATRO And RHI Traded By Insiders 11:45 a.m. Aug. 15, 2014 - TheStreet.com
Jazz Pharmaceuticals (JAZZ) Is Today's Momo Momentum Stock 9:51 a.m. Aug. 15, 2014 - TheStreet.com
Stock Market News for August 14, 2014 - Market News 10:10 a.m. Aug. 14, 2014 - Zacks.com
Jazz Pharmaceuticals (JAZZ) in Focus: Stock Surges 8.8% - Tale of the Tape 8:44 a.m. Aug. 14, 2014 - Zacks.com
Watch Out: Barbarians At The Gate For Jazz Pharmaceuticals (JAZZ) 3:55 p.m. Aug. 13, 2014 - TheStreet.com
Jazz Pharmaceuticals PLC Stock Upgraded (JAZZ) 11:12 a.m. Aug. 13, 2014 - TheStreet.com
Why Jazz Pharmaceuticals (JAZZ) Could Be an Impressive Growth Stock - Tale of the Tape 8:44 a.m. Aug. 12, 2014 - Zacks.com
3 Stocks Dragging The Health Care Sector Downward 1:04 p.m. Aug. 11, 2014 - TheStreet.com
12 Top Consensus Stock Holdings From Best 3 Health Care Active Mutual Funds 10:54 a.m. Aug. 10, 2014 - Seeking Alpha
Perilous Reversal Stock: Jazz Pharmaceuticals (JAZZ) 2:51 p.m. Aug. 7, 2014 - TheStreet.com
Jazz Pharmaceuticals Public Limited Company (JAZZ): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Aug. 7, 2014 - Zacks.com


Appointments, Market Activity, Regulatory Approvals, and Rights Acquisition - Research Reports on Nike, Morgan Stanley, Regeneron, Zimmer and Jazz 9:00 a.m. Today - PR Newswire - PRF
Box Powers Cloud Collaboration for Leading Life Sciences Organizations 12:00 p.m. Aug. 20, 2014 - BusinessWire - BZX
Critical Alerts For Kate Spade & Co, Canadian Solar, Jazz Pharmaceuticals, InterMune and Micron. Released By InvestorsObserver 9:31 a.m. Aug. 14, 2014 - PR Newswire - PRF
Product Launch, Technical Updates, Clinical Study Results, Completion of Tender Offer, and Financial Result - Research Reports on Medtronic, Covidien, Johnson & Johnson, Merck and Jazz 9:20 a.m. Aug. 11, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Pricing of $500 Million of Exchangeable Senior Notes 6:30 a.m. Aug. 8, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Proposed Offering of $500 Million of Exchangeable Senior Notes 4:05 p.m. Aug. 6, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Second Quarter 2014 Financial Results And Updated Guidance 4:05 p.m. Aug. 5, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Completes Acquisition Of Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals, Inc. 4:01 p.m. Aug. 5, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Participation at Canaccord Genuity Conference on August 13 4:10 p.m. Aug. 4, 2014 - PR Newswire - PRF
Financial Results, Clinical Trial Initiations, Drug Designations, Appointments, and Study Results - Research Reports on Cubist, Jazz, InterMune, NPS Pharmaceuticals and ACADIA 9:00 a.m. July 30, 2014 - PR Newswire - PRF
Biotech Companies Release Quarterly Financials and Announce Earnings Release Dates - Research Reports on Illumina, Alexion, Questcor, Jazz Pharmaceuticals and Exelixis 8:40 a.m. July 29, 2014 - PR Newswire - PRF
CANbridge Life Sciences And EUSA Pharma Form Agreement to Commercialize Caphosol® in China 11:34 a.m. July 28, 2014 - BusinessWire - BZX
CANbridge Life Sciences And EUSA Pharma Form Agreement to Commericalize Caphosol® in China 8:02 a.m. July 28, 2014 - BusinessWire - BZX
Equities to Watch in the Health Care Sector -- ImmunoCellular Therapeutics, Aeterna Zentaris, Lexicon Pharma, BioDelivery Sciences Intl., and Jazz Pharma 8:40 a.m. July 23, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014 4:05 p.m. July 22, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals and Concert Pharmaceuticals Provide a Phase 1 Clinical Trial Update on JZP-386 4:05 p.m. July 21, 2014 - BusinessWire - BZX
Critical Alerts For GoPro, Canadian Solar, Questcor Pharmaceuticals, Caesars Entertainment, and Jazz Pharmaceuticals Released By InvestorsObserver 9:31 a.m. July 8, 2014 - PR Newswire - PRF
Agreements, NDA Submissions, FDA Approvals, Enrollment Updates, and Index Inclusions - Analyst Notes on Jazz Pharmaceuticals, Vertex, NPS, StemCells and Achillion 5:50 a.m. July 7, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Agreement To Acquire Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals, Inc. 8:00 a.m. July 2, 2014 - PR Newswire - PRF
Pharmaceuticals Stocks Technical Momentum -- Research on Jazz Pharma, Omeros, Pernix Therapeutics Holdings, and Salix Pharma 7:10 a.m. June 16, 2014 - PR Newswire - PRF

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 4

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
USFCR Wins 2026 Award for Federal Contracting Services

Updated Category News Views 7

Award-Winning Federal Contracting Strategies News from Clearwater, Florida: US Federal Contractor Registration (USFCR) just bagged the 2026 nod from Gov Business Review as the Federal Contracting Services of the Year. Now that's a feather in the cap worth talking about. This isn't some hallway compliment, folks. It's a signal that they've nailed how to get businesses...

Continue Reading
DCM Services Teams with AKUVO to Boost Estate Recoveries

Updated Category News Views 3

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Continue Reading
Modeling and Mental Health Join Forces for Wellness

Updated Category News Views 2

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Continue Reading
Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Updated Category News Views 7

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Continue Reading
CrossCountry Mortgage Boosts Loan Limits, Flexibility for 2027

Updated Category News Views 28

Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...

Continue Reading
Veteran Marketer Joins The Wisory's Advisory Board

Updated Category News Views 5

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

Continue Reading
Melissa Rivers Brings Her Wit Back to Emmys Carpet

Updated Category News Views 5

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Continue Reading
Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 6

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 4

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading

Top 5 Most Recently Viewed Articles

BioSig Technologies Updates on Merger and Share Issuance Plans

Updated Category News Views 169

BioSig Technologies Provides Merger Update LOS ANGELES and VANCOUVER, British Columbia — BioSig Technologies, Inc. (NASDAQ: BSGM), recently provided a significant update regarding its merger with Streamex Exchange Corporation. The recent developments aim to clarify the status of the merger and ensure all shareholders are informed. Details of the Merger Finalization The...

Continue Reading
Al Hurra Cuts Jobs and Merges Iraq Channel Amid Budget Cuts

Updated Category News Views 136

Al Hurra Faces Major Workforce Reductions The parent organization of the Arabic language broadcaster Al Hurra has announced significant layoffs, resulting in the elimination of 160 positions. This decision comes in the wake of a 20% budget cut mandated by the U.S. Congress, as revealed by the company’s CEO in a message to staff. Understanding the Budget Cuts Dr. Jeffrey...

Continue Reading
Strategies for Success in Hinge Research Institute's 2025 Study

Updated Category News Views 627

Innovative Strategies Highlighted in Hinge Research's 2025 Study Hinge Research Institute stands at the forefront of research on professional services growth. With its recent 10th Annual High Growth Study, the institute has delivered crucial insights into how successful firms thrive in today’s rapidly evolving market. The study not only illustrates the growth potential...

Continue Reading
Psyence Biomed Celebrates Milestones in Psilocybin Development

Updated Category News Views 125

Recent Developments in Psyence Biomed's Journey In a significant update shared by Psyence Biomedical Ltd. (Nasdaq: PBM), the company has showcased its achievements, reflecting a positive trajectory in the realm of psychedelic-based therapeutics. Highlights from the update included the impressive valuation of their stake in PsyLabs, strong clinical trial progress, and a...

Continue Reading
Rugby Resources Limited Expands Private Placement Offerings

Updated Category News Views 146

Rugby Resources Limited Expands Private Placement Opportunities Rugby Resources Ltd. (TSX-V: RUG) has announced an important development regarding its private placement offering. Responding to high subscriber demand, the company's board has authorized an increase in the number of available units, raising the offering from 60 million units to an impressive 81.84 million...

Continue Reading